6,382 articles
A massive viral gene library exposes hundreds of proteins that suppress immune detection — with major implications for infection, cancer, and aging.
Authors reply to commentary on a landmark NEJM trial combining ianalumab and eltrombopag for immune thrombocytopenia.
Five decades after Ebola's discovery, leading virologists assess what works, what fails, and what must change in global outbreak preparedness.
Researchers outline the critical knowledge gaps blocking effective response to Bundibugyo ebolavirus, a rare but lethal filovirus.
The COMPETE trial shows radioligand therapy extends progression-free survival by nearly 10 months vs. standard targeted therapy in GEP NETs.
A Lancet commentary exposes how future physicians are discouraged from voicing views on assisted dying — with real consequences for medicine.
New research suggests latent HIV hides in more T cell types than known, reshaping strategies for an HIV cure.
A new naloxone nasal spray receives FDA approval, expanding access to life-saving opioid reversal treatment.
The WHO has issued landmark guidelines standardizing care for two of the world's deadliest viral hemorrhagic fevers.
New research reveals how a high-fat diet rewires tumor-to-nerve communication, accelerating cachexia — the devastating wasting syndrome that kills cancer patients.
Science publishes an erratum correcting a 2026 research article on detecting supramolecular organic nanoparticles during heat wave events.
Experts argue that finding new autoantibodies in encephalitis is yielding diminishing returns and call for a shift in research priorities.
